Hereditary sclerosing poikiloderma, Weary type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:221039OMIM:173700Q82.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary sclerosing poikiloderma, Weary type (also known as Weary-Kindler syndrome or hereditary sclerosing poikiloderma) is an extremely rare genodermatosis characterized by a distinctive combination of skin changes that typically begin in early childhood. The condition is classified under the broader group of inherited poikilodermas — disorders featuring mottled skin pigmentation, telangiectasia (small dilated blood vessels), and skin atrophy. The hallmark features include diffuse poikiloderma with areas of hyperpigmentation and hypopigmentation, skin sclerosis (hardening and thickening of the skin), and progressive changes that primarily affect the skin. Patients may develop scleroderma-like changes of the extremities, linear hyperkeratotic and sclerotic bands on the limbs, and widespread reticulated pigmentary changes. The condition can also be associated with palmoplantar keratoderma (thickening of the skin on palms and soles) and may involve the nails. The skin findings tend to be progressive over time. There is currently no curative treatment for hereditary sclerosing poikiloderma, Weary type. Management is supportive and symptomatic, focusing on skin care, sun protection to minimize photosensitivity-related damage, and monitoring for potential complications. Emollients and keratolytic agents may be used to manage hyperkeratotic areas. Genetic counseling is recommended for affected families. Due to the extreme rarity of this condition, much of the clinical understanding is derived from a limited number of reported families.

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hereditary sclerosing poikiloderma, Weary type.

View clinical trials →

No actively recruiting trials found for Hereditary sclerosing poikiloderma, Weary type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary sclerosing poikiloderma, Weary type community →

No specialists are currently listed for Hereditary sclerosing poikiloderma, Weary type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary sclerosing poikiloderma, Weary type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary sclerosing poikiloderma, Weary typeForum →

No community posts yet. Be the first to share your experience with Hereditary sclerosing poikiloderma, Weary type.

Start the conversation →

Latest news about Hereditary sclerosing poikiloderma, Weary type

No recent news articles for Hereditary sclerosing poikiloderma, Weary type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary sclerosing poikiloderma, Weary type

What is Hereditary sclerosing poikiloderma, Weary type?

Hereditary sclerosing poikiloderma, Weary type (also known as Weary-Kindler syndrome or hereditary sclerosing poikiloderma) is an extremely rare genodermatosis characterized by a distinctive combination of skin changes that typically begin in early childhood. The condition is classified under the broader group of inherited poikilodermas — disorders featuring mottled skin pigmentation, telangiectasia (small dilated blood vessels), and skin atrophy. The hallmark features include diffuse poikiloderma with areas of hyperpigmentation and hypopigmentation, skin sclerosis (hardening and thickening o

How is Hereditary sclerosing poikiloderma, Weary type inherited?

Hereditary sclerosing poikiloderma, Weary type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hereditary sclerosing poikiloderma, Weary type typically begin?

Typical onset of Hereditary sclerosing poikiloderma, Weary type is childhood. Age of onset can vary across affected individuals.